An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
National Institute of Environmental Health Sciences
Use this QR code to view the newest version of this document
Your Environment. Your Health.
Details for High Impact Journal
Superfund Research Program
Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association (impact factor: 11.382)
2024
Koh J, Ng CH, Nah B, Tan D, Loomba R, Huang DQ. 2024. NASH is the leading cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol 22(1):197-199. doi:10.1016/j.cgh.2023.05.019PMID:37245718
2023
Huang DQ, Tan DJ, Ng CH, Amangurbanova M, Sutter N, Tay PW, Lim WH, Yong JN, Tang A, Syn N, Muthiah M, Tan EX, Dave S, Tay B, Majzoub AM, Gerberi D, Kim BK, Loomba R. 2023. Hepatocellular carcinoma incidence in alcohol-associated cirrhosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 21(5):1169-1177. doi:10.1016/j.cgh.2022.06.032PMID:35940513
Tamaki N, Higuchi M, Kurosaki M, Loomba R, Izumi N. 2022. Risk difference of liver-related and cardiovascular events by liver fibrosis status in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 20:1171-1173. doi:10.1016/j.cgh.2021.07.021PMID:34280550PMCID:PMC8761224
2021
Stine JG, Munaganuru N, Barnard A, Wang JL, Kaulback K, Argo CK, Singh S, Fowler KJ, Sirlin C, Loomba R. 2021. Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol 19(11):2274-2283.e5. doi:10.1016/j.cgh.2020.08.061PMID:32882428PMCID:PMC7914285
Tamaki N, Munaganuru N, Jung J, Valasek MA, Behling C, Loomba R, Yonan AQ, Bettencourt R, Ajmera VH. 2021. Clinical utility of change in nonalcoholic fatty liver disease activity score and change in fibrosis in NAFLD. Clin Gastroenterol Hepatol 19(12):doi:10.1016/j.cgh.2020.11.005PMID:33157318PMCID:PMC8438785
2020
Mangla N, Ajmera VH, Caussy C, Sirlin C, Brouha SS, Bajwa-Dulai S, Madamba E, Bettencourt R, Richards L, Loomba R. 2020. Liver stiffness severity is associated with increased cardiovascular risk in patients with type 2 diabetes. Clin Gastroenterol Hepatol 18(3):744-746. doi:10.1016/j.cgh.2019.05.003PMID:31100460PMCID:PMC6984972
2019
Mills P, Caussy C, Loomba R. 2019. Glyphosate Excretion is Associated with Steatohepatitis and Advanced Liver Fibrosis in Patients with Fatty Liver Disease. Clin Gastroenterol Hepatol 18(3):741-743. doi:10.1016/j.cgh.2019.03.045PMID:30954713PMCID:PMC6776714
2017
Kim RG, Loomba R, Prokop LJ, Singh S. 2017. Statin use and risk of cirrhosis and related complications in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 15(10):1521-1530. doi:10.1016/j.cgh.2017.04.039PMID:28479502PMCID:PMC5605397
Reinders ME, Wardi G, Bettencourt R, Bouland D, Bazick J, Mendler M, Vodkin I, Kalmaz D, Savides T, Brenner DA, Sell RE, Loomba R. 2017. Increased risk of death, in the hospital and outside the intensive care unit, for patients with cirrhosis after cardiac arrest. Clin Gastroenterol Hepatol 15(11):1808-1810. doi:10.1016/j.cgh.2017.05.044PMID:28602970PMCID:PMC5723019
2015
Patel NS, Doycheva I, Peterson MR, Hooker J, Kisselva T, Schnabl B, Seki E, Sirlin CB, Loomba R. 2015. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 13(3):561-568.e1. doi:10.1016/j.cgh.2014.08.039PMID:25218667PMCID:PMC4333065
